A Cost Benefit Analysis of AminoIndex Cancer Screening in Japan
This article presents a cost benefit analysis of AminoIndex Cancer Screening (AICS) in Japan. AICS is a new cancer diagnosis method based on profiles of amino acids. The cost benefit analysis is performed on each type of cancer, each sex, and each age class. The results indicate that AICS is cost-beneficial mainly for 50-75 years old for screening of several types of cancer including stomach, lung, and colorectal cancer. AICS is also cost-beneficial for younger female for screening of uterine-ovarian cancer.
|Date of creation:||Aug 2015|
|Contact details of provider:|| Postal: 2-1 Naka, Kunitachi City, Tokyo 186-8601|
Web page: http://www.iir.hit-u.ac.jp/
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:hit:iirwps:15-14. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Digital Resources Section, Hitotsubashi University Library)
If references are entirely missing, you can add them using this form.